Potential repercussions of prescription vaping

Date:

The Federal Government’s decision to push ahead with a prescription-based model for nicotine e-cigarettes has the potential to slow the vaccine rollout and entrench a black market for vaping products.

Australia lags most of the developed world in the rollout of the COVID-19 vaccine and is well short of its own targets.

By the Federal Government’s own admission, Australia’s vaccine rollout won’t gain pace until October – the same month it was supposed to be completed with much of this work falling on GPs.

It therefore makes no sense that at a time when GPs and pharmacies workloads will be massively increasing, the government will be forcing 520,000 e-cigarette using ex-smokers into GP waiting rooms to obtain a prescription for nicotine.

The time of GPs and other health professionals is precious and finite, so it really must be queried if having 520,000 ex-smokers who are not sick and have already quit through vaping, is the best use of a their time, especially during COVID.

Read full article here.

Deborah Jackson – C-Store.com – 2021-08-03.

Want More Investigative Content?

Curate RegWatch
Curate RegWatchhttps://regulatorwatch.com
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

MORE VAPING

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party